Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.

European journal of obstetrics, gynecology, and reproductive biology - 1 Nov 2022

Matan Liat S, Perri Tamar, Kogan Liron, Brandt Benny, Meyer Raanan, Levin Gabriel

Abstract excerpt

OBJECTIVE: Germline mutations in the BRCA gene account for most hereditary ovarian and breast cancer. Management of healthy carriers aims to prevent and allow early detection of breast and ovarian cancer. This study compares six different hereditary ovarian cancer management guidelines, highlighting areas of controversy between different societies. We aim to compare international and national guidelines regarding...

Topics

Female
Humans
Carcinoma, Ovarian Epithelial
Genes, BRCA2
Mutation
Ovarian Neoplasms
Ovariectomy
Risk Factors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36208522
DOI: 10.1016/j.ejogrb.2022.09.035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.PMID 36208522Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know.Semantic proximity Read ↗

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal.Semantic proximity Read ↗

BRCA-associated ovarian cancer: from molecular genetics to risk management.Semantic proximity Read ↗

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Contemporary risk assessment and risk-reducing strategies for tubo-ovarian cancer in women with BRCA pathogenic variants.Semantic proximity Read ↗

Ovarian cancer: identifying and managing familial and genetic risk-summary of new NICE guidance.Semantic proximity Read ↗

Management updates for women with a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Hereditary Women's Cancer: Management and Risk-Reducing Surgery.Semantic proximity Read ↗

[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer].Semantic proximity Read ↗

Managing hereditary breast cancer risk in women with and without ovarian cancer.Semantic proximity Read ↗

Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.